Intravenous administration of glycyrrhizin is known to decrease elevat
ed plasma transaminase levels in patients with chronic viral hepatitis
, in which immune-mediated cytotoxicity by cytotoxic T lymphocytes and
tumour necrosis factor (TNF)-alpha is considered to play an important
pathogenic role. However, the immunological interpretation of the tra
nsaminase-lowering action of glycyrrhizin is not known. Studies were p
erformed to elucidate this action immunologically by assessing the eff
ects of glycyrrhizin on immune-mediated cytotoxicity using an antigen-
specific murine CD4(+) T hybridoma line, which exhibits cytotoxicity a
gainst antigen-presenting cells after stimulation with specific antige
n, and a murine TNF-alpha-sensitive fibroblast line. Glycyrrhizin inhi
bited the cytotoxic activity of the T cells against antigen-presenting
cells and also suppressed TNF-alpha-induced cytotoxicity in the TNF-a
lpha-sensitive cell line in vitro. These results suggest that the decr
ease of elevated transaminase levels by glycyrrhizin in patients with
chronic viral hepatitis is mediated in part by inhibition of immune-me
diated cytotoxicity against hepatocytes.